NASDAQ:EMMA - Emmaus Life Sciences News Headlines

$3.37
0.00 (0.00 %)
(As of 08/21/2019 04:00 PM ET)
Today's Range
$3.2901
Now: $3.37
$3.40
50-Day Range N/A
52-Week Range
$2.81
Now: $3.37
$14.94
Volume26,286 shs
Average Volume38,961 shs
Market Capitalization$159.96 million
P/E RatioN/A
Dividend YieldN/A
Beta2.86

Headlines

Emmaus Life Sciences (NASDAQ EMMA) News Headlines

Source:
DateHeadline
Emmaus Life Sciences (NASDAQ:EMMA) Chairman Acquires $65,910.00 in StockEmmaus Life Sciences (NASDAQ:EMMA) Chairman Acquires $65,910.00 in Stock
www.americanbankingnews.com - August 21 at 6:21 PM
Livongo Health (NASDAQ:LVGO) and Emmaus Life Sciences (NASDAQ:EMMA) Critical AnalysisLivongo Health (NASDAQ:LVGO) and Emmaus Life Sciences (NASDAQ:EMMA) Critical Analysis
www.americanbankingnews.com - August 21 at 8:45 AM
Analyzing Emmaus Life Sciences (NASDAQ:EMMA) & Catasys (NASDAQ:CATS)Analyzing Emmaus Life Sciences (NASDAQ:EMMA) & Catasys (NASDAQ:CATS)
www.americanbankingnews.com - August 19 at 2:12 PM
Pacific Health Care Organization (OTCMKTS:PFHO) vs. Emmaus Life Sciences (OTCMKTS:EMMA) Financial ReviewPacific Health Care Organization (OTCMKTS:PFHO) vs. Emmaus Life Sciences (OTCMKTS:EMMA) Financial Review
www.americanbankingnews.com - August 19 at 4:10 AM
HemaCare (OTCMKTS:HEMA) & Emmaus Life Sciences (OTCMKTS:EMMA) Critical ContrastHemaCare (OTCMKTS:HEMA) & Emmaus Life Sciences (OTCMKTS:EMMA) Critical Contrast
www.americanbankingnews.com - August 16 at 12:29 AM
Comparing Catasys (NASDAQ:CATS) & Emmaus Life Sciences (NASDAQ:EMMA)Comparing Catasys (NASDAQ:CATS) & Emmaus Life Sciences (NASDAQ:EMMA)
www.americanbankingnews.com - August 15 at 12:15 AM
Emmaus Life Sciences to Host "Sideline Sickle Cell" Community Town Hall with ASAP and FSCDR in South FloridaEmmaus Life Sciences to Host "Sideline Sickle Cell" Community Town Hall with ASAP and FSCDR in South Florida
finance.yahoo.com - August 14 at 9:28 AM
BRIEF-Emmaus Life Sciences Says Net Revenues Of EMI For 2019 Q2 Increased 128% To $5.9 MlnBRIEF-Emmaus Life Sciences Says Net Revenues Of EMI For 2019 Q2 Increased 128% To $5.9 Mln
www.msn.com - August 12 at 11:26 PM
Emmaus Life Sciences Reports Sharply Improved 2019 Second Quarter Financial ResultsEmmaus Life Sciences Reports Sharply Improved 2019 Second Quarter Financial Results
finance.yahoo.com - August 12 at 1:20 PM
Analyzing Fresenius Medical Care AG & Co. (NYSE:FMS) & Emmaus Life Sciences (NYSE:EMMA)Analyzing Fresenius Medical Care AG & Co. (NYSE:FMS) & Emmaus Life Sciences (NYSE:EMMA)
www.americanbankingnews.com - August 12 at 2:14 AM
Head-To-Head Review: Emmaus Life Sciences (NASDAQ:EMMA) versus Fresenius Medical Care AG & Co. (NASDAQ:FMS)Head-To-Head Review: Emmaus Life Sciences (NASDAQ:EMMA) versus Fresenius Medical Care AG & Co. (NASDAQ:FMS)
www.americanbankingnews.com - August 9 at 1:03 PM
BRIEF-Emmaus Life Sciences Reiterates Financial Benefits From Recent MergerBRIEF-Emmaus Life Sciences Reiterates Financial Benefits From Recent Merger
www.msn.com - August 8 at 8:23 PM
Emmaus Life Sciences Reiterates Financial Benefits from Recent MergerEmmaus Life Sciences Reiterates Financial Benefits from Recent Merger
finance.yahoo.com - August 8 at 8:23 PM
Emmaus Life Sciences (NASDAQ:EMMA) and BioRestorative Therapies (NASDAQ:BRTX) Head to Head ComparisonEmmaus Life Sciences (NASDAQ:EMMA) and BioRestorative Therapies (NASDAQ:BRTX) Head to Head Comparison
www.americanbankingnews.com - August 8 at 8:13 PM
Davita (NYSE:DVA) & Emmaus Life Sciences (NYSE:EMMA) Financial SurveyDavita (NYSE:DVA) & Emmaus Life Sciences (NYSE:EMMA) Financial Survey
www.americanbankingnews.com - August 7 at 12:36 PM
Analyzing Fresenius Medical Care AG & Co. (NYSE:FMS) and Emmaus Life Sciences (NYSE:EMMA)Analyzing Fresenius Medical Care AG & Co. (NYSE:FMS) and Emmaus Life Sciences (NYSE:EMMA)
www.americanbankingnews.com - August 5 at 4:36 PM
Comparing Emmaus Life Sciences (NASDAQ:EMMA) and BioRestorative Therapies (NASDAQ:BRTX)Comparing Emmaus Life Sciences (NASDAQ:EMMA) and BioRestorative Therapies (NASDAQ:BRTX)
www.americanbankingnews.com - August 4 at 6:40 AM
Zacks: Emmaus Life Sciences (NASDAQ:EMMA) Given $24.00 Average Price Target by AnalystsZacks: Emmaus Life Sciences (NASDAQ:EMMA) Given $24.00 Average Price Target by Analysts
www.americanbankingnews.com - August 1 at 5:48 PM
BRIEF-Emmaus Life Sciences Details Financial Benefits From Recent MergerBRIEF-Emmaus Life Sciences Details Financial Benefits From Recent Merger
www.msn.com - July 31 at 1:10 PM
Emmaus Life Sciences Details Financial Benefits from Recent Merger, including Improved Balance Sheet and Reduced Debt ServiceEmmaus Life Sciences Details Financial Benefits from Recent Merger, including Improved Balance Sheet and Reduced Debt Service
finance.yahoo.com - July 31 at 1:10 PM
This page was last updated on 8/21/2019 by MarketBeat.com Staff

Featured Article: What is a Buy-Side Analyst?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel